Evaluation of masitinib combined to gemcitabine, carboplatin or capecitabine in patients with a metastatic or locally advanced breast cancer relapsing after a first chemotherapy treatment Zhodno...

Update Il y a 4 ans
Reference: EUCTR2010-022646-24

Evaluation of masitinib combined to gemcitabine, carboplatin or capecitabine in patients with a metastatic or locally advanced breast cancer relapsing after a first chemotherapy treatment Zhodnotenie masitinibu v kombinácii s gemcitabínom, karboplatinou alebo kapecitabínom u pacientok s metastatickou alebo lokálne pokročilou rakovinou prsníka po prvej liečbe chemoterapiou